Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Solano

Showing results (241-250 of 273) with videos related to

Pageof 28
Sort By:
Bone Marrow Transplantation|November 3, 2023
Torque Teno Virus plasma DNA load: a novel prognostic biomarker in CAR-T therapyAna Benzaquén, Estela Giménez, Gloria Iacoboni, et al.
Transplantation and Cellular Therapy|December 3, 2023
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplantation for Patients with Hodgkin Lymphoma: A Comparative Study of the Lymphoma Working Party of the European Society for Blood and Marrow TransplantationJuan Montoro, Ariane Boumendil, Hervé Finel, et al.
Transplantation and Cellular Therapy|June 13, 2024
Real-World Experience with Isavuconazole in Allogeneic Stem Cell Transplantation in SpainMi Kwon, Ignacio Gómez-Centurión, Gillen Oarbeascoa, et al.
Journal of Medical Virology|March 13, 2026
Unveiling CMV Risk Signatures After Allogeneic Stem Cell Transplantation Through Machine Learning Approaches: A Multicenter Analysis From the GETH-TCEstela Giménez, Pablo Rodriguez-Belenguer, Carlos Solano, et al.
The Lancet. Haematology|February 3, 2019
Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised studyFrancesca Bonifazi, Carlos Solano, Christine Wolschke, et al.
Blood Advances|July 22, 2018
A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphismsCarolina Martínez-Laperche, Elena Buces, M Carmen Aguilera-Morillo, et al.
Viruses|October 28, 2023
Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy RecipientsJosé Luis Piñana, Inmaculada Heras, Tommaso Francesco Aiello, et al.
Frontiers in Immunology|February 19, 2021
Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell MalignanciesAgnieszka Tomaszewska, Madan Jagasia, Eric Beohou, et al.
The New England Journal of Medicine|January 7, 2016
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host DiseaseNicolaus Kröger, Carlos Solano, Christine Wolschke, et al.
Transplantation and Cellular Therapy|February 2, 2022
Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TCRebeca Bailén, María Jesús Pascual-Cascón, Manuel Guerreiro, et al.
Pageof 28

Showing results (241-250 of 273) with videos related to

Sort By:
Pageof 28
Bone Marrow Transplantation|November 3, 2023
Torque Teno Virus plasma DNA load: a novel prognostic biomarker in CAR-T therapyAna Benzaquén, Estela Giménez, Gloria Iacoboni, et al.
Transplantation and Cellular Therapy|December 3, 2023
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis in HLA-Matched and Haploidentical Donor Transplantation for Patients with Hodgkin Lymphoma: A Comparative Study of the Lymphoma Working Party of the European Society for Blood and Marrow TransplantationJuan Montoro, Ariane Boumendil, Hervé Finel, et al.
Transplantation and Cellular Therapy|June 13, 2024
Real-World Experience with Isavuconazole in Allogeneic Stem Cell Transplantation in SpainMi Kwon, Ignacio Gómez-Centurión, Gillen Oarbeascoa, et al.
Journal of Medical Virology|March 13, 2026
Unveiling CMV Risk Signatures After Allogeneic Stem Cell Transplantation Through Machine Learning Approaches: A Multicenter Analysis From the GETH-TCEstela Giménez, Pablo Rodriguez-Belenguer, Carlos Solano, et al.
The Lancet. Haematology|February 3, 2019
Acute GVHD prophylaxis plus ATLG after myeloablative allogeneic haemopoietic peripheral blood stem-cell transplantation from HLA-identical siblings in patients with acute myeloid leukaemia in remission: final results of quality of life and long-term outcome analysis of a phase 3 randomised studyFrancesca Bonifazi, Carlos Solano, Christine Wolschke, et al.
Blood Advances|July 22, 2018
A novel predictive approach for GVHD after allogeneic SCT based on clinical variables and cytokine gene polymorphismsCarolina Martínez-Laperche, Elena Buces, M Carmen Aguilera-Morillo, et al.
Viruses|October 28, 2023
Remdesivir or Nirmatrelvir/Ritonavir Therapy for Omicron SARS-CoV-2 Infection in Hematological Patients and Cell Therapy RecipientsJosé Luis Piñana, Inmaculada Heras, Tommaso Francesco Aiello, et al.
Frontiers in Immunology|February 19, 2021
Addition of Rituximab in Reduced Intensity Conditioning Regimens for B-Cell Malignancies Does Not Influence Transplant Outcomes: EBMT Registry Analyses Following Allogeneic Stem Cell Transplantation for B-Cell MalignanciesAgnieszka Tomaszewska, Madan Jagasia, Eric Beohou, et al.
The New England Journal of Medicine|January 7, 2016
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host DiseaseNicolaus Kröger, Carlos Solano, Christine Wolschke, et al.
Transplantation and Cellular Therapy|February 2, 2022
Post-Transplantation Cyclophosphamide After HLA Identical Compared to Haploidentical Donor Transplant in Acute Myeloid Leukemia: A Study on Behalf of GETH-TCRebeca Bailén, María Jesús Pascual-Cascón, Manuel Guerreiro, et al.
Pageof 28